Science & Enterprise subscription

Follow us on Twitter

  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 5 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 5 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 8 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago
  • New post on Science and Enterprise: Biotechs Partner on Gene-Edited Cancer Cell Therapies https://t.co/ck7tBkXfXF #Science #Business
    about 1 day ago

Please share Science & Enterprise

AI Gene Therapy Platform Gains $100M in Early Funds

Adeno-associated virus

A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round. . . . → Read More: AI Gene Therapy Platform Gains $100M in Early Funds

Cell Therapy Mfring Company Raises $82M in Venture Funds

T-cells and cancer cells

A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round. . . . → Read More: Cell Therapy Mfring Company Raises $82M in Venture Funds

Biomanufacturing Materials Company Issues $500M IPO

Wall Street sign

Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering. . . . → Read More: Biomanufacturing Materials Company Issues $500M IPO

Microbiome Health Company Raises $40M in Early Funds

Gut microbes illustration

A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round. . . . → Read More: Microbiome Health Company Raises $40M in Early Funds

Start-Up Designing Synthetic DNA for Gene Therapies

DNA puzzle

A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses. . . . → Read More: Start-Up Designing Synthetic DNA for Gene Therapies

AI Drug Discovery Company Acquired in $270M Deal

Four fist bump

A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms. . . . → Read More: AI Drug Discovery Company Acquired in $270M Deal

Synthetic DNA Company Raises $24M in Early Funds

DNA illustration

A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round. . . . → Read More: Synthetic DNA Company Raises $24M in Early Funds

Infographic – Global Venture Funds Hit Record High

Global venture funds, Q1 2021

Venture investing, a key source of capital for research-based companies, hit a record high level worldwide in the first quarter of 2021. . . . → Read More: Infographic – Global Venture Funds Hit Record High

Infectious Disease Biotech Raises $100M in Venture Funds

Syringe and three vials

A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds

Microsoft, Biotech Partner on Metastatic Cancer

Lung cancer illustration

A biotechnology start-up is collaborating with Microsoft Corp. on computational tools to find and predict factors that cause cancers to spread. . . . → Read More: Microsoft, Biotech Partner on Metastatic Cancer